No definition available.
Human immunodeficiency virus [HIV] disease resulting in other conditions
AB1_OTHER_CONDITIONS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
646 |
4. Check minimum number of eventsNone |
646 |
5. Include endpointsNone |
646 |
6. Filter based on genotype QC (FinnGen only) |
646 |
Control definitions (FinnGen only)
- Control exclude
- AB1_HIV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Human immunodeficiency virus [HIV] disease resulting in other conditions
based on the number of shared cases.
Similar with more cases:
- Human immunodeficiency virus [HIV] disease
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2761 | 677 | 1897 |
| Only index persons | 2352 | 643 | 1709 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.02 | 0.05 |
| Only index persons | 0.05 | 0.02 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 37.99 | 33.57 | 39.95 |
| Only index persons | 38.02 | 33.45 | 39.74 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 646 | 147 | 499 |
| Unadjusted period prevalence (%) | 0.18 | 0.05 | 0.22 |
| Median age at first event (years) | 38.38 | 35.35 | 39.28 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 590
- Matched controls
- 5898
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
+∞
323.0
572
*
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
+∞
323.0
299
*
WW200
NOMESCO Finland
Immunization
417.6
323.0
486
65
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
32.9
249.4
354
257
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
+∞
217.5
195
*
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
+∞
179.6
163
*
Z25.1
ICD-10 Finland
Need for immunization against influenza
28.0
141.5
199
105
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
12.2
104.3
208
251
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
842.0
77.1
74
*
B23.0
ICD-10 Finland
Acute HIV infection syndrome
+∞
76.8
72
*
A51.0
ICD-10 Finland
Primary genital syphilis
+∞
61.5
58
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
8.6
49.3
114
160
A54.6
ICD-10 Finland
Gonococcal infection of anus and rectum
+∞
47.5
45
*
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
471.6
44.9
44
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
43.1
318
1501
A54.5
ICD-10 Finland
Gonococcal pharyngitis
197.0
36.2
37
*
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
6.3
36.0
102
188
A51.9
ICD-10 Finland
Early syphilis, unspecified
+∞
35.8
34
*
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
14.5
34.0
58
44
A63.0
ICD-10 Finland
Anogenital (venereal) warts
7.8
31.1
74
106
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.0
30.3
106
249
A51.3
ICD-10 Finland
Secondary syphilis of skin and mucous membranes
317.8
30.1
30
*
A53.9
ICD-10 Finland
Syphilis, unspecified
152.2
27.9
29
*
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
3.0
24.9
175
729
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
+∞
24.1
23
*
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
9.3
23.3
49
57
ULA02
NOMESCO Finland
Kolposcopy
5.4
22.7
71
146
K02.9
ICD-10 Finland
Dental caries, unspecified
12.5
22.3
40
34
B18.2
ICD-10 Finland
Chronic viral hepatitis C
7.8
21.8
51
71
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.3
21.1
82
212
J05AB01
ATC
aciclovir; systemic
3.0
21.1
143
575
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.8
21.0
160
692
QAJ99
NOMESCO Finland
Other aesthetic operations on skin of head or neck
217.3
20.7
21
*
WYA30
SPAT
NA
21.0
20.6
30
15
F43.29
ICD-10 Finland
Adaptation disorder UNS
9.1
20.0
42
49
XF400
NOMESCO Finland
ECG with 12 standard connections
3.2
19.4
115
417
J05AB11
ATC
valaciclovir; oral
3.4
19.1
101
339
O98.5
ICD-10 Finland
Other viral diseases complicating pregnancy, childbirth and the puerperium
195.9
18.6
19
*
TAB00
NOMESCO Finland
Lumbar puncture
5.5
17.9
54
106
SPAT1263
SPAT
Sampling
0.3
17.8
60
1482
R4110
NOMESCO Finland
Physiotherapy
2.4
17.5
177
885
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
5.4
17.3
53
106
Z01.2
ICD-10 Finland
Dental examination
2.1
17.0
271
1671
B90
ICPC
HIV-infection/AIDS
+∞
16.7
16
*
K02.2
ICD-10 Finland
Caries of cementum
5.3
16.2
50
101
Y25
ICPC
Fear sexually transm disease male
5.6
16.1
47
89
B02.9
ICD-10 Finland
Zoster without complication
6.1
15.7
43
75
B20.9
ICD-10 Finland
HIV disease resulting in unspecified infectious or parasitic disease
+∞
15.7
15
*
C10AA07
ATC
rosuvastatin; oral
2.4
15.6
152
738
S02.51
ICD-10 Finland
Fracture of tooth, open
3.2
15.5
88
309
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
11.7
15.4
28
25
SPAT1301
SPAT
No procedures
0.3
15.4
27
922
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.7
15.2
112
466
R50.9
ICD-10 Finland
Fever, unspecified
2.8
14.9
103
412
N05CF01
ATC
zopiclone; oral
2.2
14.5
186
1027
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
37.0
14.5
18
5
ZX114
NOMESCO Finland
Intramuscular
8.0
14.3
32
42
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
0.3
14.2
29
921
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
4.0
13.9
57
154
UJF30
NOMESCO Finland
Ileoscopy through colon
3.3
13.8
73
243
EB1AA
SPAT
NA
4.1
13.5
54
143
N05CD07
ATC
temazepam; oral
3.1
13.4
76
267
SPAT1153
SPAT
Removal of sutures
0.3
12.6
34
950
Z20.6
ICD-10 Finland
Contact with and exposure to human immunodeficiency virus [HIV]
17.8
12.6
19
11
SPAT1249
SPAT
Treatment-related counselling outside office
0.4
12.6
64
1364
A55
ICD-10 Finland
Chlamydial lymphogranuloma (venereum)
+∞
12.5
12
*
WX110
SPAT
NA
3.7
12.0
53
154
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.6
12.0
96
417
R74
ICPC
Upper respiratory infection acute
2.0
11.9
184
1082
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
8.7
11.9
25
30
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.4
11.9
43
104
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
11.8
150
813
D11
ICPC
Diarrhoea
2.7
11.7
85
348
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.4
11.7
69
1395
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
23.4
11.6
16
7
C10AA01
ATC
simvastatin; oral
0.4
11.5
50
1142
SPAT1310
SPAT
Counselling related to known health issue
0.4
11.5
41
1013
B23
ICD-10 Finland
Human immunodeficiency virus [HIV] disease resulting in other conditions
+∞
11.5
11
*
A52.1
ICD-10 Finland
Symptomatic neurosyphilis
+∞
11.5
11
*
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
6.8
11.4
28
43
A01AB04
ATC
amphotericin B; local oral
5.3
11.1
33
65
TQW99
NOMESCO Finland
Other minor procedure on skin
4.5
11.0
38
88
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.7
10.5
35
78
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
14.5
10.5
17
12
A51.5
ICD-10 Finland
Early syphilis, latent
+∞
10.4
10
*
B20.0
ICD-10 Finland
HIV disease resulting in mycobacterial infection
+∞
10.4
10
*
B20.1
ICD-10 Finland
HIV disease resulting in other bacterial infections
+∞
10.4
10
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
10.3
88
394
D07AB08
ATC
desonide; topical
2.7
9.9
68
267
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
9.9
112
573
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
9.7
114
594
M01AC06
ATC
meloxicam; systemic, rectal
0.5
9.6
68
1303
UJH02
NOMESCO Finland
Anoscopy
4.0
9.6
37
96
KMAK
NOMESCO Finland
NA
1.7
9.4
340
2602
B23.2
ICD-10 Finland
HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified
+∞
9.4
9
*
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
22.1
9.4
13
6
Z71.8
ICD-10 Finland
Other specified counselling
2.0
9.3
140
805
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
2.4
9.3
82
371
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.3
9.2
28
746
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
9.2
9.1
18
20
SPAT1312
SPAT
General health counselling
0.4
8.9
44
960
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.8
8.8
55
206
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.0
8.8
34
89
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
3.1
8.7
49
169
D82
ICPC
Teeth/gum disease
0.5
8.7
87
1500
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
14.3
8.7
14
10
SPAT1097
SPAT
Recording of ECG
0.1
8.5
5
336
N05BA01
ATC
diazepam; systemic, rectal
2.3
8.5
80
376
ZXA05
NOMESCO Finland
Left side
1.9
8.5
128
734
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.2
8.4
43
141
Z30.2
ICD-10 Finland
Sterilization
0.2
8.4
7
374
A56.4
ICD-10 Finland
Chlamydial infection of pharynx
91.3
8.4
9
*
-1
NOMESCO Finland
NA
1.7
8.3
209
1418
J01MA12
ATC
levofloxacin; systemic
2.1
8.3
105
561
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
8.3
85
416
WX290
SPAT
NA
3.9
8.2
32
85
J01MA02
ATC
ciprofloxacin; systemic
1.7
8.1
206
1400
WNF00
NOMESCO Finland
Infection source and contact determination
17.5
8.1
12
7
ZXA00
NOMESCO Finland
Right side
1.9
7.9
130
768
SPAT1324
SPAT
Screening procedure
0.2
7.8
7
357
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
7.6
7.7
17
23
N06AB04
ATC
citalopram; systemic
1.9
7.6
118
682
SPAT1149
SPAT
Suture or treatment of traumatic wound
0.2
7.5
8
368
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
7.8
7.4
16
21
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.8
7.4
130
784
B21.3
ICD-10 Finland
HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue
+∞
7.3
7
*
B20.4
ICD-10 Finland
HIV disease resulting in candidiasis
+∞
7.3
7
*
B21.0
ICD-10 Finland
HIV disease resulting in Kaposi sarcoma
+∞
7.3
7
*
0788B
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[HIV-INFEKTIO,OIREISET TAUDINKUVAT]
+∞
7.3
7
*
A52.2
ICD-10 Finland
Asymptomatic neurosyphilis
+∞
7.3
7
*
A52.3
ICD-10 Finland
Neurosyphilis, unspecified
+∞
7.3
7
*
A51.4
ICD-10 Finland
Other secondary syphilis
+∞
7.3
7
*
D01AE16
ATC
amorolfine; topical
2.4
7.2
61
270
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.3
7.2
11
414
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
4.1
7.2
26
65
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.3
7.1
34
107
Z46.3
ICD-10 Finland
Fitting and adjustment of dental prosthetic device
8.1
7.1
15
19
B37.4
ICD-10 Finland
Candidiasis of other urogenital sites
12.2
7.1
12
10
JN4BD
NOMESCO Finland
Extensive body CT
2.4
7.0
57
248
D06BB04
ATC
podophyllotoxin; topical
2.6
7.0
51
210
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
2.4
6.9
57
252
B17.1
ICD-10 Finland
Acute hepatitis C
16.9
6.8
10
6
N05BA04
ATC
oxazepam; oral
1.8
6.7
126
775
5AB01
NOMESCO Finland
NA
22.8
6.7
9
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
0.2
6.7
9
363
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
6.6
86
464
M01AH05
ATC
etoricoxib; oral
0.6
6.6
211
2765
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
12.4
6.6
11
9
SPAT1216
SPAT
Assessment of functional ability
0.2
6.5
5
284
Z01.7
ICD-10 Finland
Laboratory examination
2.2
6.5
64
306
D06BB10
ATC
imiquimod; topical
3.6
6.5
27
77
B59
ICD-10 Finland
Pneumocystosis
70.6
6.4
7
*
A52.9
ICD-10 Finland
Late syphilis, unspecified
70.6
6.4
7
*
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
70.6
6.4
7
*
HMAK
NOMESCO Finland
NA
0.3
6.4
13
422
P01AB01
ATC
metronidazole; oral, rectal
1.6
6.4
185
1288
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.3
6.4
57
263
K05.31
ICD-10 Finland
Periodontitis pronounced
2.2
6.4
63
301
OAB43
SPAT
NA
0.5
6.3
49
925
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.2
6.3
61
291
C10AA05
ATC
atorvastatin; oral
0.5
6.3
71
1198
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.4
6.3
24
585
0788C
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[AIDS, IMMUUNIKATO]
+∞
6.3
6
*
Y71
ICPC
Gonorrhoea male
+∞
6.3
6
*
TLC02
NOMESCO Finland
Simple extraction of IUD
3.9
6.2
24
64
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
0.1
6.2
*
231
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
6.2
88
493
T74.1
ICD-10 Finland
Physical abuse
4.2
6.1
21
51
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
617
17
8063.55
307.65
16.2
1.2
u/ml
3067.1
—
—
381
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
499
469
43.36
307.65
2.5
3.1
u/l
27.7
141.1
0.61
494
418
(3017143) Hepatitis C virus Ab [Presence] in Serum
602
730
107.39
307.65
5.6
1.6
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
556
23
1728.97
307.65
3.0
2.9
%
31.2
41.6
—
91
8
(40758558) Short blood count panel - Blood
575
1186
36.01
307.65
13.4
6.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
593
132
536.38
307.65
7.6
3.7
g/l
0.1
0.3
2.95
581
62
(3021879) Hepatitis B virus core Ab [Presence] in Serum
568
466
93.67
307.65
5.0
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
533
1000
25.75
307.65
3.5
2.9
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
479
43
428.04
307.65
2.3
2.3
e6/l
926.6
716.7
1.12
13
24
(21494815) CD4 cells/100 lymphocytes in Specimen
577
40
1342.15
307.65
2.9
2.0
%
38.5
44.4
—
8
8
(42870588) Differential panel, method unspecified - Blood
616
1665
59.13
284.24
13.8
6.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
581
1524
28.95
270.22
4.9
3.5
e6/l
31.7
91.8
1.12
262
1093
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
524
1345
16.33
240.11
1.9
1.7
mmol/l
1.4
1.6
2.33
519
1158
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
111
13
102.89
213.93
3.3
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
615
2230
37.63
196.62
18.8
9.1
e9/l
0.0
0.0
0.63
600
1830
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
162
104
20.46
195.07
1.1
1.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
624
2324
50.48
194.07
18.9
6.4
%
0.8
0.7
4.31
624
2212
(3006504) Eosinophils/100 leukocytes in Blood
625
2394
50.55
186.98
18.9
6.3
%
2.9
3.0
0.45
625
2276
(3016650) Hepatitis A virus Ab [Presence] in Serum
164
117
18.45
186.84
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
133
60
27.65
186.49
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
294
495
10.06
185.81
2.8
1.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
626
2413
52.50
185.80
18.9
6.6
%
8.9
8.8
0.77
626
2307
(3018010) Neutrophils/100 leukocytes in Blood
626
2456
51.03
181.08
18.7
6.1
%
50.0
56.9
54.92
626
2345
(3002030) Lymphocytes/100 leukocytes in Blood
626
2489
49.94
177.54
18.9
6.3
%
36.5
28.3
77.29
626
2373
(3001604) Monocytes [#/volume] in Blood
633
2561
74.13
176.47
18.8
6.2
e9/l
0.5
0.6
10.80
625
2257
(3006315) Basophils [#/volume] in Blood
633
2565
73.94
176.06
18.8
6.2
e9/l
0.0
0.0
0.66
625
2264
(3019198) Lymphocytes [#/volume] in Blood
633
2642
70.37
168.32
18.8
6.3
e9/l
2.2
1.9
10.17
625
2366
(3013115) Eosinophils [#/volume] in Blood
633
2645
70.23
168.03
19.0
6.6
e9/l
0.2
0.2
4.22
625
2368
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
197
238
11.47
160.03
5.9
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
584
2321
16.80
157.61
7.1
4.1
estimate
0.0
0.0
0.50
41
438
(3035350) Ketones [Presence] in Urine by Test strip
584
2324
16.76
157.30
4.0
2.9
estimate
0.0
0.0
0.00
41
419
(3009261) Glucose [Presence] in Urine by Test strip
585
2336
16.93
156.91
4.0
2.9
estimate
0.0
0.0
0.00
37
393
(3025130) Human papilloma virus identified in Specimen
104
41
30.04
152.41
2.7
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
634
2898
64.94
145.87
19.8
9.8
e9/l
3.1
4.1
49.80
626
2546
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
205
299
9.58
142.80
6.0
1.8
—
—
—
0
0
(3013762) Body weight Measured
127
0
+∞
137.53
1.2
0.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
637
3764
50.68
124.22
11.9
7.9
u/l
75.8
77.1
0.46
637
3582
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
148
177
10.55
119.34
3.1
3.3
mg/l
1.2
1.4
2.89
141
167
(3037467) Urinalysis macro (dipstick) panel - Urine
624
3219
28.56
113.35
8.6
3.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
142
177
10.00
110.59
1.2
1.3
miu/ml
178.9
227.8
0.57
49
83
(36304419) Bacteria [Presence] in Urine
346
1214
4.98
90.94
3.1
2.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
346
1220
4.95
90.21
3.1
2.9
e6/l
0.1
0.4
2.98
253
903
(3052851) Hemolysis interference index of Serum or Plasma
102
119
9.99
82.71
2.3
3.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
351
1331
4.59
81.28
3.1
3.0
e6/l
36.2
90.4
0.54
260
1018
(21494814) CD8 cells/100 lymphocytes in Specimen
56
24
25.45
78.63
4.8
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
236
685
4.85
76.87
4.3
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
249
760
4.70
75.96
4.9
1.9
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
49
16
33.06
75.37
5.4
1.8
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
61
44
15.20
67.29
4.5
2.0
%
9.8
12.6
—
5
19
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
57
37
16.80
66.48
5.2
2.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
67
59
12.55
65.66
4.8
2.3
e9/l
1.5
1.2
1.12
51
28
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
224
706
4.33
64.10
2.6
2.7
e6/l
1.9
1.3
0.33
98
365
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
227
751
4.12
60.29
2.6
2.6
e6/l
1.1
1.1
0.07
101
410
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
355
1600
3.71
59.25
3.3
3.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
65
68
10.52
56.60
2.1
2.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
57
50
12.41
55.84
2.1
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
63
66
10.47
54.77
1.1
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
637
5030
20.12
51.87
22.0
10.8
ml/min/173m2
88.6
89.2
0.39
616
4182
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
102
199
5.90
51.38
1.4
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
633
4525
20.82
51.01
27.8
14.8
%
13.3
13.5
4.11
633
4444
(3009871) Measles virus Ab [Titer] in Serum
37
21
18.63
45.80
1.3
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
90
175
5.81
45.32
1.1
1.7
iu/ml
0.2
0.1
0.31
54
30
(3026782) Osmolality of Urine
210
832
3.26
40.15
2.7
2.6
mosm/kgh2o
645.1
594.2
2.32
185
719
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
214
874
3.17
38.66
1.5
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
212
879
3.10
37.10
2.6
2.5
e6/l
3.7
4.8
0.47
192
785
(3003327) Ova and parasites identified in Stool by Light microscopy
78
163
5.31
36.08
2.6
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
622
4841
8.67
33.62
8.5
4.9
mmol/mol
35.2
39.3
33.19
622
4622
(3016244) Insulin [Units/volume] in Serum or Plasma
35
34
10.83
31.81
6.7
3.4
mu/l
46.3
25.3
1.94
35
34
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
24
12
20.73
31.18
1.2
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
73
168
4.77
30.05
1.4
1.8
g/l
1.2
1.5
2.10
64
154
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
49
82
6.38
28.51
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
49
82
6.38
28.51
1.2
1.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
37
45
8.66
28.50
3.0
2.5
e6/l
977.5
797.7
0.36
27
38
(3013707) Erythrocyte sedimentation rate by Westergren method
509
3627
2.90
27.83
3.9
3.8
mm/h
10.8
9.1
2.01
502
3423
(1761868) Lipid panel - Serum or Plasma
107
2499
0.31
27.81
4.0
2.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
613
4910
5.86
27.17
28.9
14.7
g/l
336.7
335.4
2.93
613
4887
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
27
24
11.70
25.94
3.7
2.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
184
848
2.64
25.08
1.4
1.5
nmol/l
18.8
20.0
0.84
176
755
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
35
49
7.49
23.96
4.3
3.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
107
385
3.13
23.00
2.2
2.4
ml/min/173m2
77.5
73.6
0.57
55
146
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
54
123
4.70
22.40
1.3
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
626
5298
6.86
21.25
28.7
12.5
%
42.4
42.0
1.25
596
4367
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
13
15.03
21.13
2.2
1.8
iu/ml
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
254
1492
2.16
18.98
4.4
3.5
mmol/l
9.1
9.0
0.03
240
1290
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
639
5817
10.09
18.65
22.3
9.5
u/l
32.8
32.4
0.22
639
5681
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
28
41
7.09
18.38
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
28
41
7.09
18.38
1.1
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
20
20
10.29
17.67
1.0
1.2
umol/l
30.6
25.1
1.83
20
20
(3006922) Hepatitis E virus Ab [Presence] in Serum
28
45
6.46
16.87
1.1
1.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
616
5307
4.46
16.85
13.5
12.2
mg/l
23.6
22.9
0.19
460
4118
(40761511) CBC panel - Blood by Automated count
490
5666
0.44
16.29
8.6
11.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
209
1227
2.04
14.94
3.1
4.2
ph
7.4
7.4
0.06
17
232
(3001964) Herpes simplex virus Ag [Presence] in Specimen
20
9
22.88
14.29
1.2
3.7
—
—
—
0
0
(3013512) EKG study
45
1215
0.32
13.06
1.6
3.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
53
175
3.21
13.00
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
71
280
2.73
12.70
1.7
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
244
1587
1.86
12.44
1.7
1.8
pmol/l
94.5
96.3
0.31
138
908
(42529406) Shigella sp [Presence] in Stool by Culture
49
159
3.25
12.36
1.8
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
162
932
1.99
11.89
2.1
2.0
mg/l
2.5
2.9
1.07
140
822
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
98
1815
0.46
11.64
2.5
3.0
ng/l
23.3
38.7
0.87
41
1123
(3006653) Thiamine [Moles/volume] in Blood
19
34
5.73
10.27
1.0
1.1
nmol/l
149.3
153.0
0.11
19
34
(3019225) pH of Specimen
5
380
0.12
10.18
2.8
4.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
96
482
2.16
10.05
1.6
1.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
34
100
3.53
10.00
4.0
3.8
e9/l
2.9
4.2
5.79
34
100
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
337
4201
0.59
9.94
3.0
3.3
u/l
56.7
52.7
0.37
320
4019
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
33
96
3.57
9.87
2.3
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
34
101
3.50
9.86
4.0
4.2
%
48.7
56.4
3.51
34
101
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
96
491
2.12
9.57
1.6
1.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
44
159
2.90
9.26
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
44
159
2.90
9.26
1.3
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
43
156
2.88
8.99
2.4
3.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
40
960
0.38
8.66
1.3
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
83
422
2.11
8.38
1.5
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
44
169
2.72
8.28
1.1
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
16
30
5.44
8.24
1.7
3.6
u/ml
1365.3
620.2
1.12
16
30
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
11
523
0.20
8.17
7.8
6.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
31
812
0.35
8.08
1.4
1.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
5
22.34
8.03
4.5
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
116
1849
0.55
8.00
4.8
2.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
54
239
2.37
7.61
5.5
3.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
40
153
2.72
7.60
3.3
3.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
36
132
2.83
7.41
1.1
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
53
237
2.35
7.30
1.5
1.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
639
6128
4.95
6.96
29.7
17.4
g/l
143.1
142.6
0.35
639
6066
(3024731) MCV [Entitic volume]
639
6125
4.99
6.95
29.6
17.3
fl
93.2
90.3
40.65
639
6067
(3035941) MCH [Entitic mass]
639
6124
5.01
6.94
29.5
17.2
pg
31.5
30.4
35.98
639
6065
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
63
310
2.14
6.91
1.4
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
21
58
3.71
6.80
2.0
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
16
37
4.41
6.52
2.8
2.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
81
449
1.92
6.41
1.8
2.5
g/l
0.3
0.2
1.67
75
418
(3004446) Plasmodium sp identified in Blood by Light microscopy
10
7
14.48
6.41
5.3
2.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
185
1302
1.59
6.25
2.9
3.4
mg/l
401.4
209.3
0.25
135
900
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
28
99
2.91
6.17
2.1
4.0
—
2809.3
—
0
10
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
134
2.62
6.13
1.2
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
251
1903
1.52
6.04
6.4
7.2
mmol/l
1.2
1.2
0.21
242
1765
(3002032) Base excess in Venous blood by calculation
75
415
1.91
5.97
2.7
3.5
mmol/l
0.3
1.9
2.45
60
339
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
99
602
1.76
5.83
2.3
3.1
umol/l
9.6
9.0
0.12
86
542
(3051651) Icteric interference index of Serum or Plasma
14
32
4.45
5.79
3.2
5.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
73
409
1.88
5.60
13.0
11.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
170
1209
1.55
5.39
5.2
4.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
98
610
1.72
5.30
1.4
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
542
0.37
5.24
1.1
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
8
301
0.26
5.21
2.3
7.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
164
1166
1.54
5.18
2.1
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
61
334
1.91
5.02
3.4
2.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
131
892
1.59
4.98
3.0
3.5
ng/l
81.3
660.5
3.34
92
657
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
52
271
2.00
4.94
2.0
4.4
ng/l
75.2
88.8
0.92
52
250
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
17
52
3.33
4.77
1.1
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
63
356
1.85
4.72
3.3
2.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
63
357
1.85
4.68
3.3
2.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
229
0.21
4.64
1.4
3.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
91
579
1.67
4.53
1.9
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
63
361
1.83
4.52
3.3
2.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
63
362
1.82
4.48
3.4
2.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
92
1372
0.62
4.46
4.9
2.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
14
40
3.56
4.35
3.4
4.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
167
2184
0.68
4.30
3.1
3.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
16
51
3.19
4.23
1.3
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
203
2554
0.70
4.18
3.3
3.5
ug/l
2.1
1.7
0.47
190
2362
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
259
2096
1.39
4.00
6.0
7.8
mmol/l
1.2
1.2
0.49
235
1807
(3023520) Reticulocytes [#/volume] in Blood
54
307
1.83
3.99
1.4
2.7
e9/l
66.8
73.3
0.61
24
227
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
11
28
3.98
3.99
1.0
1.0
iu/ml
12.2
4.6
—
5
8
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
155
2033
0.69
3.98
2.6
3.2
%
24.4
21.4
0.71
55
716
(1001926) Buprenorphine [Presence] in Urine by Screen method
51
285
1.86
3.98
3.2
2.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
52
296
1.82
3.84
1.3
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
79
1181
0.62
3.82
5.8
3.2
estimate
0.0
0.0
0.80
41
413
(3023511) Choriogonadotropin [Units/volume] in Urine
18
66
2.78
3.78
1.4
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
255
0.31
3.78
2.0
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
86
1257
0.64
3.75
7.1
4.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
138
1011
1.46
3.67
1.6
1.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
9
7.85
3.56
1.1
3.9
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
6
212
0.28
3.55
2.7
3.2
mmol/l
24.9
24.7
—
6
207
(3049717) Cytology report of Urine Cyto stain
30
145
2.12
3.53
2.1
2.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
89
0.00
3.52
0.0
1.8
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
6
10.08
3.50
1.5
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
99
686
1.52
3.45
1.6
1.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
13
338
0.37
3.34
1.3
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
138
1039
1.42
3.15
1.3
1.4
g/l
3.2
2.5
1.42
58
716
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
69
450
1.60
3.14
2.9
3.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
92
2.33
3.13
2.1
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
218
1775
1.34
3.07
2.2
2.3
nmol/l
73.1
72.5
0.10
211
1645
(3002619) Bacteria identified in Specimen by Culture
6
8
7.56
3.06
1.0
1.1
—
—
—
0
0
(4094501)
5
178
0.28
3.01
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
63
2.58
2.97
1.4
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
22
101
2.22
2.96
2.2
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
80
0.00
2.94
0.0
1.8
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
12
41
2.96
2.87
1.5
2.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
53
812
0.62
2.82
1.6
1.6
pmol/l
405.9
36783642.0
0.97
46
715
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
11
36
3.09
2.82
1.2
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
43
257
1.72
2.75
17.7
15.0
mmol/l
24.1
24.6
0.49
37
247
(3044290) Cell count panel - Cerebral spinal fluid
24
118
2.07
2.75
1.9
1.4
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
6
10
6.04
2.70
1.0
1.0
mg/g
11.4
6.4
—
6
10
(3039443) Prostate specific Ag panel - Serum or Plasma
11
278
0.39
2.69
2.0
1.6
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
8
19
4.25
2.68
1.0
1.4
u/l
15.1
14.5
—
8
19
(3036489) Thrombin time
36
207
1.78
2.63
2.0
2.4
s
22.4
21.5
0.52
36
180
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
33
185
1.83
2.62
1.9
2.6
%
94.1
92.9
0.12
33
177
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
11
5.49
2.55
1.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
6
11
5.49
2.55
1.2
2.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
10
33
3.06
2.53
1.0
1.1
iu/ml
720.0
193.2
—
10
33
(3042936) Bacteria identified in Isolate by Culture
96
704
1.43
2.53
2.2
2.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
19
88
2.19
2.53
1.1
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
83
2.20
2.43
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
18
83
2.20
2.43
1.3
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
80
1091
0.70
2.41
2.5
3.1
ng/l
949.3
948.9
0.00
71
903
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
12
5.04
2.40
1.0
2.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
12
5.04
2.40
1.2
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
440
4024
1.29
2.39
3.6
3.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
21
106
2.01
2.28
2.5
3.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
60
0.00
2.25
0.0
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
30
172
1.78
2.24
1.7
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
18
86
2.12
2.24
1.4
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
29
3.13
2.23
1.0
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
15
308
0.47
2.22
1.9
3.2
kpa
4.7
5.2
3.09
15
291
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
138
1100
1.32
2.18
1.3
1.3
u/ml
2.9
1.6
0.36
12
330
(3009343) pH of Capillary blood
15
304
0.48
2.15
1.9
3.2
ph
7.4
7.4
—
6
40
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
21
109
1.96
2.12
1.0
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
60
841
0.68
2.10
1.3
1.2
iu/ml
22.7
25.9
0.10
17
261
(3001122) Ferritin [Mass/volume] in Serum or Plasma
228
1953
1.26
2.05
2.4
2.7
ug/l
150.8
152.6
0.03
219
1860
(3037522) Nuclear Ab [Titer] in Serum
95
723
1.37
2.03
1.3
1.3
titre
280.0
378.0
0.50
18
131
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
63
2.25
2.02
1.7
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
44
2.53
2.02
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
44
2.53
2.02
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
44
2.53
2.02
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
44
2.53
2.02
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
44
2.53
2.02
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
44
2.53
2.02
1.0
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
15
70
2.17
1.99
1.1
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
18
330
0.53
1.92
3.3
3.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
13
58
2.27
1.92
2.5
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
15
291
0.50
1.91
1.9
3.3
mmol/l
0.3
1.6
—
7
216
(3026493) Urate [Moles/volume] in Serum or Plasma
112
1396
0.76
1.88
1.7
2.5
umol/l
3531.4
4078.6
0.06
97
1275
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
23
129
1.81
1.88
2.2
3.5
u/ml
0.5
0.3
—
9
73
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
34
2.67
1.87
1.3
1.1
—
—
—
0
0
(4034850)
7
168
0.41
1.80
4.1
9.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
20
109
1.86
1.79
1.5
3.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
36
2.52
1.74
1.0
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
59
426
1.42
1.74
1.5
2.5
g/l
12.2
10.5
1.85
53
393
(3040151) Glucose [Moles/volume] in Capillary blood
0
46
0.00
1.71
0.0
7.3
—
7.1
—
0
41
(3018677) aPTT in Platelet poor plasma by Coagulation assay
92
717
1.33
1.71
2.5
2.4
s
31.1
29.9
1.42
92
701
(3020682) Albumin/Creatinine [Ratio] in Urine
163
1370
1.25
1.69
3.5
4.2
mg/mmol
13.4
9.8
0.35
118
933
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
49
0.00
1.69
0.0
3.2
—
56.6
—
0
39
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
18
97
1.88
1.67
1.4
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
18
97
1.88
1.67
1.3
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
18
97
1.88
1.67
1.3
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
18
97
1.88
1.67
1.3
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
48
336
1.46
1.67
1.3
1.8
g/l
1.1
1.3
0.60
43
317
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
19
3.18
1.66
1.2
2.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
19
3.18
1.66
1.2
2.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
69
2.05
1.65
1.5
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
43
2.35
1.61
1.5
2.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
25
152
1.67
1.59
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
130
1.72
1.55
1.0
1.2
u/ml
371.9
235.3
0.80
15
85
(4146454)
0
42
0.00
1.53
0.0
3.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
17
93
1.85
1.53
2.1
4.2
u/ml
4.3
133.7
0.49
17
88
(3000034) Microalbumin [Mass/volume] in Urine
0
43
0.00
1.52
0.0
2.9
—
40.8
—
0
35
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
27
2.61
1.52
1.0
1.0
miu/ml
1932.6
1396.0
—
7
27
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
27
2.61
1.52
1.1
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
36
243
1.51
1.50
1.1
1.1
—
13.5
—
0
6
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
167
0.47
1.49
1.1
2.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
14
254
0.54
1.49
1.0
1.1
—
—
—
0
0
(4027681)
9
37
2.45
1.48
1.2
1.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
57
423
1.38
1.46
1.8
1.9
nmol/l
49.5
36.7
2.26
57
416
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
28
2.52
1.45
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
25
384
0.64
1.41
1.8
2.1
ug/l
9.1
9.3
0.02
20
360
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
7
29
2.43
1.39
2.7
2.1
—
411.8
—
0
5
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
60
782
0.74
1.39
1.3
1.2
u/ml
20.3
8.7
0.30
13
334
(36660697) Celiac disease serology panel - Serum
54
401
1.38
1.39
1.1
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
18
104
1.75
1.38
1.4
1.6
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
18
104
1.75
1.38
2.8
4.3
kpa
9.6
9.0
1.37
18
104
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
22
135
1.65
1.37
1.8
2.5
ug/min
174.3
128.4
0.21
15
76
(40768797) Stomach Pathology biopsy report
79
624
1.30
1.36
1.2
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
125
1480
0.81
1.36
1.3
1.4
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
37
0.00
1.34
0.0
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
18
105
1.73
1.34
2.8
4.3
mmol/l
1.3
2.6
—
8
71
(3013290) Carbon dioxide [Partial pressure] in Blood
18
105
1.73
1.34
2.8
4.3
kpa
4.7
5.1
1.98
18
105
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
39
0.00
1.34
0.0
2.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
54
2.06
1.33
1.1
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
40
0.00
1.33
0.0
1.3
—
1.1
—
0
16
(3038026) Centromere Ab [Units/volume] in Serum
0
40
0.00
1.33
0.0
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
40
0.00
1.33
0.0
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
24
2.51
1.30
1.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
24
2.51
1.30
1.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
77
611
1.30
1.29
1.6
1.6
nmol/l
871.4
1161.6
2.63
67
488
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
22
139
1.60
1.24
1.1
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
22
140
1.59
1.21
1.1
1.3
mg/l
536.5
499.2
0.22
22
133
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
131
1115
1.22
1.21
1.9
1.8
mg/l
2.2
1.1
0.42
101
845
(3015171) Extractable nuclear Ab [Units/volume] in Serum
11
199
0.55
1.19
1.1
1.2
—
1.6
—
0
19
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
6
26
2.32
1.19
1.3
3.3
—
63716.1
—
0
7
(3045414) Leukocytes [Presence] in Urine
11
198
0.55
1.17
1.3
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
34
0.00
1.16
0.0
2.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
13
222
0.58
1.16
2.1
2.6
e6/l
0.1
0.1
0.07
13
214
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
36
0.00
1.14
0.0
1.1
—
98.6
—
0
28
(40768443) Skin Pathology biopsy report
26
176
1.50
1.12
1.1
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
51
1.98
1.11
1.2
2.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
12
66
1.83
1.09
1.8
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
21
2.39
1.09
1.0
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
103
866
1.23
1.08
2.3
2.4
nmol/l
17.3
14.3
3.17
97
796
(40768800) Prostate Pathology biopsy report
6
123
0.48
1.06
1.0
1.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
5
22
2.28
1.03
1.2
5.2
mg/l
69.8
79.8
—
5
16
(3013139) Helicobacter pylori Ag [Presence] in Stool
40
299
1.36
1.03
1.3
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
46
592
0.76
1.01
1.2
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
81
669
1.24
1.01
3.4
3.2
mmol/l
2.4
2.4
0.10
64
596
(40768804) Tissue Pathology biopsy report
200
1798
1.16
1.00
2.0
1.9
—
—
—
0
0
(3002256) Pathology report gross observation
67
543
1.26
0.98
1.3
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
30
0.00
0.97
0.0
2.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
30
0.00
0.97
0.0
1.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
549
5322
1.21
0.97
14.6
13.7
mmol/l
3.9
4.0
8.42
535
5201
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
31
0.00
0.96
0.0
2.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
116
0.51
0.95
1.2
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
62
1.79
0.94
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
62
1.79
0.94
1.1
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
84
994
0.82
0.92
5.2
3.1
kg/l
1.0
1.0
—
6
110
(4198724)
8
44
1.83
0.86
1.8
1.9
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
31
1.94
0.84
1.3
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
45
1.79
0.84
1.0
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
8
137
0.58
0.84
1.0
1.2
—
18.2
—
0
17
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
8
137
0.58
0.84
1.0
1.2
—
3.6
—
0
11
(3022621) pH of Urine by Test strip
17
249
0.67
0.83
1.9
2.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
89
1.59
0.81
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
25
0.00
0.79
0.0
1.8
—
9.6
—
0
18
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
25
0.00
0.79
0.0
1.2
—
6.8
—
0
25
(3026470) Cobalt [Mass/volume] in Blood
0
25
0.00
0.79
0.0
2.0
—
3.9
—
0
25
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
26
0.00
0.78
0.0
2.9
—
37.1
—
0
7
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
82
1.60
0.78
1.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
27
0.00
0.77
0.0
3.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(4024509)
0
27
0.00
0.77
0.0
1.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
17
115
1.49
0.77
1.4
2.4
mg/l
49.8
37.8
0.62
17
82
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.9
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
0
28
0.00
0.76
0.0
1.4
—
28.9
—
0
21
(3024471) HLA-A [Type]
0
28
0.00
0.76
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
3.2
—
80.8
—
0
28
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
15
99
1.53
0.76
1.5
1.3
u/ml
1.3
4.3
—
8
34
(4268621)
11
67
1.65
0.75
3.0
2.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
32
246
1.32
0.73
1.3
2.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
26
1.93
0.70
4.8
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
22
161
1.38
0.69
1.5
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
27
1.86
0.68
2.6
2.2
—
—
—
0
0
(3010421) pH of Blood
18
127
1.43
0.68
2.8
4.1
ph
7.4
7.4
0.06
18
105
(4035726)
44
357
1.25
0.68
1.3
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
28
214
1.32
0.68
1.2
1.4
iu/l
15.8
20.6
0.47
17
180
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
43
1.63
0.67
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
43
1.63
0.67
1.1
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
70
1.58
0.65
1.0
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
138
1523
0.88
0.65
2.2
2.4
ug/l
0.7
0.7
0.04
102
778
(3012095) Magnesium [Moles/volume] in Serum or Plasma
90
791
1.16
0.62
2.4
4.0
mmol/l
0.8
0.8
0.13
79
756
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
103
0.58
0.62
1.0
2.0
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
31
244
1.28
0.62
1.2
1.5
—
9.1
—
0
11
(3021901) Oxygen saturation in Capillary blood
11
71
1.56
0.62
2.1
2.8
—
—
—
0
0
(3000492) Spirometry study
60
702
0.84
0.62
1.4
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
14
96
1.47
0.62
1.6
1.6
e6/l
1109.0
10365.9
—
5
69
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
30
1.67
0.61
1.4
2.8
%
106.2
90.3
—
5
30
(3036603) Volume of Urine
5
30
1.67
0.61
1.8
1.6
—
1572.0
—
0
5
(3019550) Sodium [Moles/volume] in Serum or Plasma
542
5297
1.14
0.60
13.8
13.7
mmol/l
139.1
139.7
6.95
530
5180
(3037556) Urate [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
6.9
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
21
0.00
0.60
0.0
4.8
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.1
—
7.9
—
0
5
(1002224) Polysomnography panel
30
376
0.79
0.59
1.1
1.0
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
17
230
0.73
0.58
1.7
2.4
%
0.6
0.7
0.29
17
225
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
16
115
1.40
0.57
1.2
2.4
mg/l
42.2
33.8
0.42
16
83
(21494890) Protein electrophoresis panel - 24 hour Urine
6
36
1.67
0.57
1.0
2.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
36
1.67
0.57
1.0
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
88
0.56
0.56
1.0
2.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
89
0.56
0.56
1.8
3.8
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
6
37
1.63
0.55
1.0
1.5
u/l
5.1
8.8
—
6
31
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
123
0.65
0.55
1.0
2.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
61
1.48
0.54
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
74
1.49
0.53
1.1
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
113
1027
1.12
0.50
2.2
2.1
%
1.6
1.5
1.44
100
932
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
10
144
0.69
0.49
1.0
1.2
—
35.5
—
0
5
(4010399)
28
344
0.81
0.49
1.4
1.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
13
93
1.41
0.48
1.2
1.1
—
11.4
—
0
7
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
111
0.63
0.48
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
76
1.46
0.48
1.1
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
146
1351
1.10
0.47
5.3
3.5
mmol/l
2.4
2.3
0.45
130
1227
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
22
276
0.79
0.46
27.3
15.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
95
859
1.12
0.46
2.9
2.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
154
1431
1.10
0.45
2.2
2.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
26
210
1.25
0.45
1.3
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15
113
1.34
0.43
1.1
2.4
—
1.1
—
0
11
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
70
1.44
0.42
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
15
0.00
0.41
0.0
1.1
—
2.4
—
0
15
(1617658) Protocol used for examination of sentinel lymph nodes
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
17
0.00
0.40
0.0
8.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.8
—
17.3
—
0
18
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.3
—
9.2
—
0
18
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
18
0.00
0.40
0.0
2.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
103
0.68
0.39
1.4
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
105
0.66
0.39
1.0
1.2
—
1.0
—
0
6
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
19
0.00
0.39
0.0
1.1
—
9.4
—
0
19
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
19
0.00
0.39
0.0
3.0
—
24.9
—
0
19
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
19
0.00
0.39
0.0
7.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
53
599
0.87
0.39
1.5
1.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
36
1.39
0.38
1.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
67
1.35
0.38
1.0
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
76
0.66
0.36
1.0
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
78
0.64
0.36
1.6
3.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
82
1.35
0.34
1.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
348
3581
0.94
0.33
2.6
3.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
21
174
1.21
0.32
1.5
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
52
1.35
0.31
1.0
1.5
g/l
1.1
1.0
—
7
52
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
12
153
0.78
0.31
1.1
1.1
—
7.0
—
0
21
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
24
203
1.19
0.30
1.4
1.7
—
277.1
—
0
7
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
55
1.28
0.30
1.0
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
57
1.23
0.29
1.0
2.5
—
—
—
0
0
(44790049)
8
63
1.27
0.28
1.0
2.1
—
—
—
0
0
(44806118)
8
63
1.27
0.28
1.0
2.1
—
—
—
0
0
(44790047)
8
63
1.27
0.28
1.0
2.1
—
—
—
0
0
(44790048)
8
63
1.27
0.28
1.0
2.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
121
0.74
0.27
1.0
2.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
79
1.27
0.22
1.3
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
135
0.81
0.22
1.2
1.8
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
5.2
—
0
11
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
11
0.00
0.21
0.0
1.2
—
40.2
—
0
11
(3034988) Calcium [Moles/volume] in Capillary blood
0
11
0.00
0.21
0.0
1.1
—
1.2
—
0
11
(4015189)
0
11
0.00
0.21
0.0
2.9
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
11
0.00
0.21
0.0
1.2
—
1.7
—
0
11
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
0.5
—
0
6
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
10
0.00
0.21
0.0
1.1
—
44.6
—
0
10
(46235168) Fasting glucose [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
12
0.00
0.21
0.0
1.2
—
1.2
—
0
12
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
177
0.84
0.21
3.2
3.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
4.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
13
0.00
0.21
0.0
3.5
—
5992.6
—
0
13
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
13
0.00
0.21
0.0
9.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
261
0.88
0.20
1.3
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.1
—
0.8
—
0
9
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
50
1.20
0.19
1.0
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
69
647
1.07
0.19
1.7
2.6
ug/g
149.2
120.4
0.27
54
549
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
66
704
0.93
0.19
1.5
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
51
1.18
0.19
4.2
1.6
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
36
388
0.92
0.14
2.2
2.3
—
22.1
—
0
35
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
14
157
0.89
0.11
1.1
2.1
mg/l
12.3
10.5
1.53
14
151
(3050129) First trimester maternal screen panel - Serum or Plasma
13
116
1.12
0.09
1.2
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
63
0.79
0.08
2.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
30
284
1.06
0.07
1.1
1.2
iu/ml
125.8
140.1
—
6
106
(40767503) Oxygen content in Capillary blood by calculation
7
84
0.83
0.07
2.9
2.7
%
19.8
16.8
—
7
44
(44816559) Phosphatidylethanol [Mass/volume] in Blood
18
167
1.08
0.07
1.4
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
93
0.86
0.06
1.0
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
15
138
1.09
0.06
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
27
256
1.06
0.06
1.4
1.4
u/l
12.2
6.1
0.85
17
214
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
90
1.11
0.05
1.6
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
52
536
0.97
0.05
15.2
11.4
mmol/l
-0.3
1.1
1.51
37
430
(3003740) Influenza virus B Ag [Presence] in Specimen
15
139
1.08
0.05
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
91
1.10
0.04
1.1
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
10
109
0.92
0.04
1.0
1.2
—
25.6
—
0
8
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
11
102
1.08
0.03
1.3
1.2
%
119.6
115.3
0.20
11
94
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
108
0.92
0.03
1.3
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
178
1793
0.99
0.02
5.7
7.8
inr
1.2
1.2
0.16
36
540
(40761536) Microorganisms panel - Urine sediment
38
389
0.98
0.02
7.9
3.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
358
3592
0.99
0.02
2.7
3.3
pmol/l
13.6
14.6
14.00
342
3345
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
109
1098
0.99
0.01
2.3
2.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
11
116
0.95
0.00
1.2
1.5
—
62.1
—
0
39
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
13
124
1.05
0.00
1.4
2.3
u/ml
23.3
31.7
0.37
13
118
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
449
4497
0.99
0.00
3.8
3.8
mu/l
1.9
2.1
0.41
431
4220
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
196
0.97
0.00
2.1
2.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
105
1.05
0.00
1.3
1.2
—
—
—
0
0
(4306422)
11
106
1.04
0.00
1.3
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
265
0.98
0.00
1.1
1.1
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
53
534
0.99
0.00
15.7
11.3
kpa
12.2
12.5
0.17
47
512
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
53
534
0.99
0.00
15.7
11.4
kpa
5.0
5.2
0.53
47
509
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
99
1.01
0.00
1.1
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
71
0.99
0.00
1.3
2.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
2.0
—
2.2
—
0
5
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
8
0.00
0.00
0.0
2.6
—
0.4
—
0
8
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
5.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
13.6
—
0
5
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4038314)
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
51
0.98
0.00
1.0
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
24
240
1.00
0.00
1.6
1.6
mu/l
258.6
261.5
0.04
24
223
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
193.7
—
0
6
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
1.5
—
0
6
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
105.3
—
0
6
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
2.0
—
0
9
(44806420)
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
87
0.92
0.00
1.0
2.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
65
0.92
0.00
2.0
3.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
7
0.00
0.00
0.0
4.6
—
212.9
—
0
7
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
7.5
—
0
6
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
2.5
—
0
7
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
53
0.94
0.00
2.2
2.8
umol/l
2.6
6.9
—
5
40
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_OTHER_CONDITIONS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_CONDITIONS | 4.108 [2.91, 5.8] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.455 |
During the follow-up period (1.1.1998 — 31.12.2019), 54 out of 643 females with AB1_OTHER_CONDITIONS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_CONDITIONS | 2.837 [2.42, 3.32] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.018 |
During the follow-up period (1.1.1998 — 31.12.2019), 266 out of 1729 males with AB1_OTHER_CONDITIONS died.
Mortality risk
Mortality risk for people of age
years, who have AB1_OTHER_CONDITIONS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.439% | 0.538% |
| 5 | 2.69% | 3.498% |
| 10 | 5.971% | 8.836% |
| 15 | 12.195% | 15.784% |
| 20 | 20.703% | 25.317% |
Relationships between endpoints
↥Index endpoint: AB1_OTHER_CONDITIONS – Human immunodeficiency virus [HIV] disease resulting in other conditions
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data